Market Access Views & Analysis

Views & Analysis

Market Access

England’s Innovative Medicines Fund hits another milestone

Leela Barham takes a look at the latest milestone on what will have been a close to three-year journey to an Innovative Medicines Fund (IMF) in England.

Market Access

FDA’s treatment of China-developed drugs spurs demands for m...

China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline.

Market Access

Is it time to rethink electronic prescribing in the US?

It is a fact of life that most – if not all – patients will require some form of prescription medication during their lifetime.

Market Access

Combination pricing: access to the future of oncology treatm...

Combination therapies are fast becoming the cornerstone of cancer treatment: not just in the UK, but across the world.

Market Access

Orphan drugs' financial success raises questions

R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any.

Market Access